Related Experiment Video
Updated: Aug 11, 2026
Giant Liposome Preparation for Imaging and Patch-Clamp Electrophysiology
Published on: June 21, 2013
Preparation and properties of liposome-associated gentamicin
Abstract:
Gentamicin was successfully incorporated into neutral, anionic, and cationic liposomes, and the percentage of gentamicin incorporated was found to be a function of lipid concentration. Gentamicin did not leak out of the liposomes over a 3-week period at 4 degrees C. When liposome-associated gentamicin was administered intravenously to rabbits, its serum half-life was greatly prolonged. Intragastric administration of dipalmitoylphosphatidylcholine liposomes containing gentamicin resulted in the appearance of gentamicin in serum. Liposome-associated gentamicin, when administered intravenously, led to the appearance of gentamicin in the liver and spleen, which was not observed when rabbits were injected with free gentamicin.
Insights
Gentamicin incorporated into liposomes showed prolonged serum half-life and targeted delivery to organs like the liver and spleen in rabbits. This liposomal gentamicin formulation offers potential for improved therapeutic efficacy.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Biotechnology
Background:
- Gentamicin is an aminoglycoside antibiotic crucial for treating bacterial infections.
- Conventional gentamicin administration faces challenges like nephrotoxicity and limited serum half-life.
- Liposomes offer a promising nanocarrier system for improving drug pharmacokinetics and targeting.
Purpose of the Study:
- To investigate the successful incorporation and stability of gentamicin within various liposome formulations.
- To evaluate the pharmacokinetic profile and biodistribution of liposome-encapsulated gentamicin following intravenous and intragastric administration in rabbits.
Main Methods:
- Gentamicin was encapsulated into neutral, anionic, and cationic liposomes.
- Liposome-drug incorporation efficiency was analyzed as a function of lipid concentration.
- In vitro stability of liposomal gentamicin was assessed over three weeks at 4°C.
- Pharmacokinetic studies involved intravenous and intragastric administration of liposomal gentamicin to rabbits, with serum gentamicin levels monitored over time.
- Biodistribution analysis was performed by quantifying gentamicin in liver and spleen tissues.
Main Results:
- Gentamicin was successfully incorporated into neutral, anionic, and cationic liposomes, with incorporation percentage dependent on lipid concentration.
- No significant gentamicin leakage from liposomes was observed over a 3-week period at 4°C, indicating good stability.
- Intravenous administration of liposome-associated gentamicin in rabbits resulted in a significantly prolonged serum half-life compared to free gentamicin.
- Intragastric administration of dipalmitoylphosphatidylcholine liposomes containing gentamicin led to detectable gentamicin in serum.
- Intravenous administration of liposome-associated gentamicin resulted in its accumulation in the liver and spleen, a phenomenon not observed with free gentamicin.
Conclusions:
- Liposomal encapsulation enhances the stability and prolongs the serum half-life of gentamicin.
- Liposome-associated gentamicin demonstrates potential for targeted delivery to organs such as the liver and spleen.
- This liposomal formulation presents a viable strategy for improving gentamicin's therapeutic index and efficacy.
